Georgia 2023-2024 Regular Session

Georgia House Bill HB257

Introduced
2/6/23  

Caption

Health; feminine hygiene products containing restricted substances; prohibit distribution or sale

Impact

The passage of HB 257 is aimed at protecting consumers from potentially harmful ingredients found in common feminine hygiene products. By setting standards for ingredient safety, this bill aligns with increasing public concern over health-related product safety and could lead to broader regulatory changes in the personal care and hygiene market. Manufacturers will need to adapt their products to ensure compliance, which could also lead to innovation in the development of safer alternatives.

Context

Overall, HB 257 represents a growing legislative trend focused on consumer protection and health safety. As societal awareness of the impacts of chemical safety in everyday products becomes more pronounced, bills like this highlight the importance of legislative action in safeguarding public health. Monitoring and enforcing these new standards will be critical to ensuring the desired outcomes are achieved without unnecessary disruption to the market.

Summary

House Bill 257, also known as the Menstrual Product Protection Act, seeks to enhance public health and safety by prohibiting the distribution, sale, or offering for sale of feminine hygiene products containing specific restricted substances in Georgia. The bill identifies these products as tampons, pads, cups, and similar items, and outlines a list of harmful substances that are the focus of this prohibition, including lead, mercury, and various chemical compounds known to pose health risks. The legislation will take effect on July 1, 2024, providing a timeline for compliance by manufacturers and sellers.

Contention

While the bill primarily focuses on health and safety, it may face opposition from industries that produce feminine hygiene products. Concerns about the financial implications for manufacturers and retailers may arise, particularly regarding the costs associated with reformulating products to comply with the new regulations. Additionally, some stakeholders might question the effectiveness of such a legislative approach compared to voluntary industry standards and consumer education on product safety.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.